Mohammad Haskali

Dr. Mohammad Haskali

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2019 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
NZNicholas A. Zia
Nicholas A. Zia
CCCarleen Cullinane
Carleen Cullinane
JZJessica K. Van Zuylekom
Jessica K. Van Zuylekom
KWKelly Waldeck
Kelly Waldeck
LMLachlan E. McInnes
Lachlan E. McInnes
PDPaul S. Donnelly
Paul S. Donnelly

13 May 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
Shuiyu LuShuiyu Lu
Shuiyu Lu
MHMohammad Haskali
Mohammad Haskali
KRKevin M. Ruley
Kevin M. Ruley
NDNicolas J.-F. Dreyfus
Nicolas J.-F. Dreyfus
SDSusan L. DuBois
Susan L. DuBois
VPVictor Pike
Victor Pike
Two radioligands, [ 18 F]LSN3316612 and [ 11 C]LSN3316612, image and quantify brain O -linked-β- N -acetyl-glucosamine hydrolase in vivo.

20 March 2023 in Chemistry – A European Journal
Verified
Journal Article
Closed access
STSanjay Telu
Sanjay Telu
SJSusovan Jana
Susovan Jana
MHMohammad Haskali
Mohammad Haskali
BYBo Yeun Yang
Bo Yeun Yang
JJJimmy E. Jakobsson
Jimmy E. Jakobsson
VPVictor Pike
Victor Pike

7 April 2021 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ACAlicia Corlett
Alicia Corlett
Marc-antoine SaniMarc-antoine Sani
Marc-antoine Sani
JZJessica Van Zuylekom
Jessica Van Zuylekom
CAChing-Seng Ang
Ching-Seng Ang
EGElisabeth von Guggenberg
Elisabeth von Guggenberg
MHMohammad Haskali
Mohammad Haskali

8 November 2021 in Australian Journal of Chemistry
Verified
Journal Article
Open access
PDF file
AHAndrew J. Hall
Andrew J. Hall
MHMohammad Haskali
Mohammad Haskali
Theranostics are drugs suitable for use in both diagnostic and therapeutic applications, and have played an important role in the advancement of modern nuclear medicine. This review explains key elements that are common to successful theranostics and highlights significant developments in the field, including our own. Specific focus is given to peptides and those features that make them most suitable for theranostic application, as well as some key radioisotopes owing to their favourable properties and high clinical utility. This report provides an overview of the techniques at the researcher’s disposal, how they have been applied to current clinically significant targets, and how they might be used and improved upon for future targets.

27 May 2025 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
WHWilliam W. Hunt
William W. Hunt
MLMathew Long
Mathew Long
UKUsama Kamil
Usama Kamil
SKSunil Kellapatha
Sunil Kellapatha
WNWayne Noonan
Wayne Noonan
MHMohammad Haskali
Mohammad Haskali